ArticleIndian journal of gastroenterology : official journal of the Indian Society of Gastroenterology2022

Efficacy and safety of biosimilar versus originator infliximab in patients with inflammatory bowel disease: A real-world cohort analysis.

Peeyush Kumar et al.PubMed ↗Publisher ↗

No numbers read from the abstract.